DirectorMoves Eli Kalif
Teva Pharmaceutical (NYSE: TEVA) $9.26b Eli Kalif named CFO xo Flex Ltd SVP Finance
$$$$ Base $650,000; Bonus 100% of base; Sign-on equity award RSUs value at $250,000
https://www.tevapharm.com/about/corporate_governance/board_of_directors/